Reduction of Tinnitus Severity by the Centrally Acting Muscle Relaxant Cyclobenzaprine: An Open-Label Pilot Study

URN to cite this document:: urn:nbn:de:bvb:355-epub-408931
DOI to cite this document:: 10.5283/epub.40893

Coelho, Claudia ; Figueiredo, Ricardo ; Frank, Elmar ; Burger, Julia ; Schecklmann, Martin

; Landgrebe, Michael ; Langguth, Berthold

; Belen Elgoyhen, Ana

Preview

PDF - Published Version
(306kB)

Date of publication of this fulltext: 23 Oct 2019 10:20

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Tinnitus, the phantom perception of sounds, is a highly prevalent disorder. Although a wide variety of drugs have been investigated off label for the treatment of tinnitus, there is no approved pharmacotherapy. We report an open-label exploratory pilot study to assess the effect of muscle relaxants acting on the central nervous system on tinnitus patients. Cyclobenzaprine at high (30 mg) and low ...